CN111328967A - 一种制备供高血脂患者食用的保健粥的方法 - Google Patents
一种制备供高血脂患者食用的保健粥的方法 Download PDFInfo
- Publication number
- CN111328967A CN111328967A CN201811555206.5A CN201811555206A CN111328967A CN 111328967 A CN111328967 A CN 111328967A CN 201811555206 A CN201811555206 A CN 201811555206A CN 111328967 A CN111328967 A CN 111328967A
- Authority
- CN
- China
- Prior art keywords
- parts
- porridge
- traditional chinese
- health
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021395 porridge Nutrition 0.000 title claims abstract description 76
- 230000036541 health Effects 0.000 title claims abstract description 46
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 84
- 235000013305 food Nutrition 0.000 claims abstract description 35
- 239000000284 extract Substances 0.000 claims abstract description 30
- 244000075850 Avena orientalis Species 0.000 claims abstract description 24
- 240000007594 Oryza sativa Species 0.000 claims abstract description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 23
- 235000009566 rice Nutrition 0.000 claims abstract description 23
- 240000008042 Zea mays Species 0.000 claims abstract description 22
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 22
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 22
- 235000005822 corn Nutrition 0.000 claims abstract description 22
- 235000013312 flour Nutrition 0.000 claims abstract description 20
- 235000007215 black sesame Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 235000016709 nutrition Nutrition 0.000 claims abstract description 8
- 230000035764 nutrition Effects 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 25
- 235000013399 edible fruits Nutrition 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 24
- 235000007319 Avena orientalis Nutrition 0.000 claims description 23
- 235000012907 honey Nutrition 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241000830535 Ligustrum lucidum Species 0.000 claims description 18
- 240000000249 Morus alba Species 0.000 claims description 18
- 235000008708 Morus alba Nutrition 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 238000000227 grinding Methods 0.000 claims description 15
- 238000007873 sieving Methods 0.000 claims description 15
- 244000197580 Poria cocos Species 0.000 claims description 14
- 235000008599 Poria cocos Nutrition 0.000 claims description 14
- 238000010298 pulverizing process Methods 0.000 claims description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 13
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 13
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 12
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 12
- 241000005787 Cistanche Species 0.000 claims description 11
- 241001289529 Fallopia multiflora Species 0.000 claims description 11
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 11
- 235000011477 liquorice Nutrition 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 241001080798 Polygala tenuifolia Species 0.000 claims description 10
- 241001633680 Polygonatum odoratum Species 0.000 claims description 10
- 235000019640 taste Nutrition 0.000 claims description 10
- 244000163122 Curcuma domestica Species 0.000 claims description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 7
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 7
- 241001521901 Tribulus lanuginosus Species 0.000 claims description 7
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 6
- 241000756042 Polygonatum Species 0.000 claims description 6
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 235000003373 curcuma longa Nutrition 0.000 claims description 6
- 239000000049 pigment Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 229960004793 sucrose Drugs 0.000 claims description 6
- 235000013976 turmeric Nutrition 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 241000675108 Citrus tangerina Species 0.000 claims description 5
- 241000146384 Glaux Species 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 45
- 238000011282 treatment Methods 0.000 abstract description 25
- 229940079593 drug Drugs 0.000 abstract description 21
- 235000005911 diet Nutrition 0.000 abstract description 9
- 230000037213 diet Effects 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 description 57
- 210000003734 kidney Anatomy 0.000 description 51
- 210000004185 liver Anatomy 0.000 description 51
- 210000004369 blood Anatomy 0.000 description 43
- 239000008280 blood Substances 0.000 description 43
- 206010062717 Increased upper airway secretion Diseases 0.000 description 27
- 208000026435 phlegm Diseases 0.000 description 27
- 210000001124 body fluid Anatomy 0.000 description 22
- 239000010839 body fluid Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 21
- 230000009466 transformation Effects 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 17
- 230000001105 regulatory effect Effects 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 238000005728 strengthening Methods 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 241000159213 Zygophyllaceae Species 0.000 description 7
- 230000001174 ascending effect Effects 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 239000004519 grease Substances 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 description 6
- 235000007558 Avena sp Nutrition 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- 230000001914 calming effect Effects 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000004064 dysfunction Effects 0.000 description 6
- 235000009165 saligot Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 238000012536 packaging technology Methods 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 238000009499 grossing Methods 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000019633 pungent taste Nutrition 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000202726 Bupleurum Species 0.000 description 2
- 244000201986 Cassia tora Species 0.000 description 2
- 235000014552 Cassia tora Nutrition 0.000 description 2
- 241000336291 Cistanche deserticola Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000208966 Polygala Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000011284 combination treatment Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000005068 transpiration Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000209514 Alismataceae Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000984231 Atractylodes chinensis Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 description 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 description 1
- 208000031288 Combined hyperlipidaemia Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 244000077283 Distichlis palmeri Species 0.000 description 1
- 235000005422 Distichlis palmeri Nutrition 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 241000208977 Polygalaceae Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008876 liujunzi Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000009765 shen ling bai zhu Substances 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000021139 traditional diet Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Insects & Arthropods (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种制备供高血脂患者食用的保健粥的方法,属于功能性食品领域。本发明方法以燕麦、玉米粉、粳米、黑芝麻和中药提取物为原料精心配伍制得保健粥。与现有技术相比,本发明保健粥的技术优势在于,其秉承中国传统药膳的理念,将食品和药品的功效完美融合、相辅相成,既可以起到营养保健、辅助治疗的功效,又最大限度的避免了药物带来的毒副作用,适合患者长期食用;并且其保健效果好、应用范围广、制造工艺简便易行、易于推广应用。
Description
技术领域
本发明涉及一种制备供高血脂患者食用的保健粥的方法,属于功能性食品领域。
技术背景
药膳发源于我国传统的饮食和中医食疗文化,药膳是在中医学、烹饪学和营养学理论指导下,严格按药膳配方,将中药与某些具有药用价值的食物相配伍,采用我国独特的饮食烹调技术和现代科学方法制作而成的具有一定色、香、味、形的美味食品。它是中国传统的医学知识与烹调经验相结合的产物。它“寓医于食”,既将药物作为食物,又将食物赋以药用,药借食力,食助药威,二者相辅相成,相得益彰;既具有较高的营养价值,又可防病治病、保健强身、延年益寿。
高脂血症是指人体内的脂肪代谢紊乱而形成的血浆脂质中一种或多种成分的浓度超过正常高限的一种病症,可表现为高胆固醇血症、高甘油三酯血症或二者兼有(混合型高脂血症)。高脂血症与动脉粥样硬化、冠心病、脑血管病、肥胖、脂肪肝等病症的发生发展关系密切。中医整体调节机体机能,防治高脂血症疗效显著,副作用小,被患者接受。
高脂血症“本”为“虚”
中医学认为血脂由水谷所化生,与津液同源,随津液的流行而敷布,注骨、益髓、泽肤、填充体腔而发挥正常的生理效应,与现代医学所谓之血脂相类。若脏腑功能失调,则气血运行不畅,津液不归正化,从浊生脂聚痰,浸淫脉道,以致气滞血瘀痰凝,痹阻脉络而发为本病。中医理论中高脂血症的病因包括:饮食失节,嗜食肥甘厚味,食滞胃肠,脾气受困,脾之清气不能化浊,致痰浊留滞脉中而发为本病;好逸恶劳,养尊处优,气血壅滞,脾阳不振,运化失常,导致膏脂生成与转化的障碍;情志不畅,七情致病,内伤五脏,则气、血、津、液运化失常,致膏脂输布、运化障碍而成高脂血症;先天禀赋不足,或年老肾精亏虚,肾主水,肾虚则津液代谢失调,致膏脂转运障碍。本病的发生与肝、脾、肾三脏关系密切,肝、脾、肾三脏功能失调为本。
1、脾运失常,运化障碍成高脂血症
脾为后天之本,主运化,升清,为气血生化之源。清代张志聪对膏脂有过详尽的论述:“中焦之气,蒸津液化,其精微……溢于外则皮肉膏肥,余于内则膏脂丰满。”可见膏脂源于水谷由中焦气化而来,与津液同源,随津液流行、敷布。水谷化生为精微并输布至全身,均依赖于脾的运化。因此,脾运正常,水津四布,膏脂可入内、溢外,发挥濡养的作用;脾运失常,水津不布,精化为浊,致膏脂输布运化障碍,而成高脂血症。脾气亏虚、脾阳不足以及湿阻中焦,均可导致脾失健运。脾气亏虚的主症包括:腹胀纳呆,大便溏薄,少气懒言,倦怠乏力,面色萎黄或淡白,舌淡苔白,脉缓弱。治宜益气健脾,方选六君子汤加减。脾阳不足的主症包括:脘腹冷痛绵绵,喜暖喜按,泛吐清水,口淡不渴,腹胀食少,大便清稀或完谷不化,或带下清稀色白量多,舌淡胖边有齿痕,苔白滑,脉沉迟无力。治宜理气健脾、温阳除湿,方选理中丸加减。湿阻中焦症见:头晕,头重如裹,嗜睡乏力,周身重,口中黏腻,腹满腹胀,食少纳呆呕恶,大便不实或泄泻,舌淡或有齿痕,舌苔白腻,脉濡缓。治宜运脾化湿浊,方选胃苓汤加减。
2、肝病可致使气血津液运行不畅
肝藏血,主疏泄,具有调畅气机,调节情志,疏泄胆汁助消化等作用。肝气冲合条达,则全身气机调畅,血脉运行畅通。而情志不畅,致肝气郁滞,肝失于疏泄则土气壅滞,脾气运化失常,进而膏脂输布、运化障碍而成高脂血症。另一方面,如《血证论》中所言:“肝主藏血……其所以能藏之故,则以肝属木,木气冲和条达,不致遏郁,则血脉得畅。”也就是说:肝气冲和条达,气机调畅,才能保证血脉运行畅通。故肝病可使气血津液运行不畅,膏脂停于脉中而发病。肝郁气滞的主症包括:情志抑郁或易怒,喜太息,胸胁或少腹胀满窜痛;妇女可见乳房胀痛、月经不调等,舌淡红苔薄白,脉弦。治宜疏肝健脾,活血化瘀,选用柴胡疏肝散、参苓白术散、四物汤等加减化裁,或于原方中加入柴胡、厚朴、香橼、佛手、枳壳、当归、丹参、桃仁、红花等疏肝理气、化瘀之品。
3、肾阳不足,痰浊内蕴
肾为先天之本,肾藏精,肾主水。肾中阴阳为一身阴阳之根本,人年老,肾中阴阳渐衰,则水液失其主宰,疏布失调,津液流行异常,水聚成痰。肾为水火既济之脏,肾阴亏虚则虚火旺盛,炼液为痰。肾阳乃人身之少火,一身气机的运行有赖于下元的温煦与蒸腾气化,肾阳不足,致蒸腾无权,气化失司,遂致津液停聚,痰浊内蕴。另外,肾为先天之本,脾为后天之本,脾运离不开肾阳的温煦,则肾阳亏虚可致脾失健运、痰浊内蕴,继而发病。肾阴虚以腰膝酸软、眩晕耳鸣、失眠多梦、形体消瘦、潮热盗汗、五心烦热等为主症,舌红少苔或无苔,脉细数。治宜滋补肾阴,选用知柏地黄丸、左归丸加减。肾阳虚症见腰膝酸软冷痛、畏寒肢冷、神疲乏力等症,舌淡苔白,脉沉细无力,尺部尤甚。治宜温补肾阳,选用肾气丸、右归丸加减。
4、“标”是痰浊和瘀血
痰浊和瘀血属人体津血代谢失常的病理产物,二者均为阴邪,直接阻碍了津液、膏脂的运化与输布。津液停聚而生痰湿,痰湿阻塞脉道,气机受阻,血行不畅而成瘀;血瘀可致液聚成痰,痰聚益助血瘀,血瘀与痰浊,二者同为致病因素,又可互为因果,从而引发高脂血症,进而引起诸多并发症如动脉粥样硬化、冠心病等,均与之有密切关系。
中医论治高脂血症从调理肝、脾、肾三脏入手,并注重化痰祛瘀。肝、脾、肾三脏互相关联:肝主疏泄,气机调畅有助于脾的运化和升清。而脾的运化,升清又有助于肝的疏泄升发。肝脾调和,水谷精微的运化、输布正常,则痰湿无以生,病安从来。肾主藏精,为先天之本,脾之健运,化生精微,须借助于肾阳的温煦及肾阴的滋养;而肾中精气亦有赖于后天水谷精微的培育和充养,才能不断充盈和成熟。肝肾同源,肝血为肾精所化生,厥阴必待少阴之精足方能血充气畅,疏泄条达。
正所谓母子相生,精血同源。所以,临证遣方用药时需注意:治疗从整体入手,不可孤立地只看肝、脾、肾之中某一脏,而要综观全身脏腑间的相互作用。如出现脾肾两虚,肝脾不调,肝肾阴虚等症,在治疗时应注意先、后天并补,疏肝不忘实脾以及滋补肝肾之阴。治疗高脂血症在固本的同时不忘治标,配合应用化痰、祛瘀、通腑等法。
发明内容
本发明要解决的技术问题是,开发一种专供高血脂患者使用的功能食品,使该食品在满足常规营养需求的基础上,对患者的高血脂病症有一定的保健和辅助治疗效果。为解决该技术问题,发明人从中国传统的药膳理念出发,精心选择对高血脂症有益的谷物和中药组方,然后以营养学理论和中医中药理论为依据,通过反复试验配伍比例,并通过动物实验和临床验证,最终发明一种保健粥及其制备方法。
本发明一种制备供高血脂患者食用的保健粥的方法,所述保健粥的配方以重量份可以表示为:燕麦20-60份、玉米粉15-50份、粳米2-30份、黑芝麻0.1-10份、中药提取物3-12份;
中药提取物的配方:女贞子17-29份、苍术10-22份、泽泻9-21份、决明子11-25份、何首乌8-20份、玉竹12-24份、郁金7-17份、蒺藜9-21份、茯苓10-22份、丹参8-16份、肉苁蓉6-10份、远志7-15份、桑葚子18-34份、蜂蜜7-17份、陈皮8-18份、甘草8-14份;
所述制备保健粥的方法为以下步骤:
(1)按本发明中药组方称取各味中药材;
(2)将苍术、何首乌、甘草炒制,分别粉碎,磨细,过80-120目筛,得细粉a,备用;
(3)将决明子、蒺藜、黑芝麻、茯苓、丹参、肉苁蓉分别粉碎,研磨,过80-120目筛,得细粉b,备用;
(4)将女贞子、玉竹、桑葚子、泽泻、郁金、远志、陈皮分别粉碎,混合后加入6-13倍重量的纯化水,回流煎煮三次,每次1-4小时,过滤,合并滤液,浓缩至60℃相对密度为1.23-1.26的浓缩液,备用;
(5)将步骤(4)中制得的浓缩液加入蜂蜜,混合均匀,继续浓缩至60℃相对密度为1.30-1.35 的稠膏,减压干燥,得干浸膏,粉碎磨细,过80-120目筛,得细粉c;
(6)将细粉a、b、c混合均匀,得中药提取物,备用;
(7)将燕麦、黑芝麻粉碎与玉米粉、粳米混合,加5-16倍的水,熬制30-120分钟,将中药提取物安配比加入,混合均匀,继续熬制2-15分钟,即为保健粥的原料粥;
(8)在步骤(7)的原料粥中加入蔗糖、食盐、香精、色素等辅料,可以制成各种口味的保健营养粥,也可以通过真空干燥等技术制成可以冲泡的粉状粥,然后利用现代通用的食品包装技术可以制成各种方便携带食用的包装形式,如碗粥、易拉罐、袋装粥等。
发明过程中优选出来的具有较佳疗效的配方配比为(以重量份计):
燕麦45份、玉米粉35份、粳米12份、黑芝麻2份、中药提取物6份;
中药组方通过临床实践优选为如下3个疗效最佳的配比:
配比1:女贞子23份、苍术16份、泽泻15份、决明子18份、何首乌14份、玉竹18份、郁金12份、蒺藜15份、茯苓16份、丹参12份、肉苁蓉8份、远志11份、桑葚子26份、蜂蜜12份、陈皮13份、甘草11份;
配比2:女贞子25份、苍术18份、泽泻16份、决明子17份、何首乌15份、玉竹17份、郁金11份、蒺藜14份、茯苓15份、丹参13份、肉苁蓉9份、远志12份、桑葚子27份、蜂蜜13份、陈皮14份、甘草12份;
配比3:女贞子24份、苍术17份、泽泻14份、决明子19份、何首乌16份、玉竹18份、郁金13份、蒺藜16份、茯苓15份、丹参13份、肉苁蓉7份、远志13份、桑葚子28份、蜂蜜11份、陈皮14份、甘草12份。
本发明所公开的保健粥的原料的特点及功效:
燕麦:燕麦,又名雀麦、野麦。燕麦一般分为带稃型和裸粒型两大类。其营养功效为:富含淀粉、蛋白质、脂肪、B族维生素、尼克酸、叶酸、泛酸、钙、铁等营养成分,具有益肝和胃、养颜护肤等功效。燕麦还能够抗细菌、抗氧化的功效,在春季能够有效的增加人体的免疫力,抵抗流感。
(1)燕麦可以有效地降低人体中的胆固醇,经常食用,即可对中老年人的主要威胁——心脑血管病起到一定的预防作用
(2)经常食用燕麦对糖尿病患者也有非常好的降糖的功效
(3)燕麦粥有通大便的作用,很多老年人大便干,容易导致脑血管意外,燕麦能解便秘之忧
(4)它还可以改善血液循环,缓解生活工作带来的压力;含有的钙、磷、铁、锌等矿物质有预防骨质疏松、促进伤口愈合、防止贫血的功效,是补钙佳品
(5)燕麦中含有极其丰富的亚油酸,对脂肪肝、糖尿病、浮肿、便秘等也有辅助疗效,对老年人增强体力,延年益寿也是大有裨益的。
玉米粉:玉米粉又称玉蜀黍粉。玉米是世界公认的“黄金作物”,其脂肪、磷元素、维生素B2的含量居谷类食物之首,玉米面中含有亚油酸和维生素E,能使人体内胆固醇水平降低,从而减少动脉硬化的发生,玉米面中含钙、铁质较多,可防止高血压、冠心病。
粳米:粳米是大米的一种,常见的主食。主要产于中国东北。粳米中含有丰富的蛋白质,所含人体必需的氨基酸也比较全面,还含有脂肪、钙磷、铁及B族维生素等多种营养成分。
粳米具有养阴生津、除烦止渴、健牌胃、补中气、固肠止泻的功效。用粳米煮米粥时,浮在锅面上的浓稠液体(俗称米汤、粥油),具有补虚的功效,对于病后产后体弱的人有辅助疗效。粳米的糙米比精白米更有营养,它能降低胆固醇,减少心脏病发作和中风的概率。适宜一切体虚之人、高热之人、久病初愈、妇女产后、老年人、婴幼消化力减弱者煮成稀粥调养食用。
黑芝麻:黑芝麻为胡麻科脂麻的黑色种子,含有大量的脂肪和蛋白质,还有糖类、维生素A、维生素E、卵磷脂、钙、铁、铬等营养成分。大量研究表明,芝麻素具有很强的抗氧化能力,还能够降低血清胆固醇水平,尤其是明显降低动脉硬化危险因子LDL-C(低密度脂蛋白)另外,芝麻木脂素在保护肝脏、降低血糖、控制血压、调节免疫及抑制肿瘤方面也具有很好的作用。
本发明中药组方中所涉及的中药材的性质及功用:
女贞子:本品为木犀科植物女贞的干燥成熟果实。味甘、苦,性凉;归肝、肾经;滋补肝肾,明目乌发。
苍术:本品为菊科植物茅苍术或北苍术的干燥根茎。味辛、苦,性温;归脾、胃、肝经;燥湿健脾,祛风散寒,明目。
泽泻:本品为泽泻科植物泽泻的干燥块茎。味甘,性寒;归肾、膀胱经;利小便,清湿热。
决明子:本品为豆科植物决明或小决明的干燥成熟种子。味甘、苦、咸,性微寒;归肝、大肠经;清热明目,润肠通便。
何首乌:本品为蓼科植物何首乌的干燥块根,其藤茎称“夜交藤”。味苦,甘,涩;性微温;归肝,肾经;养血滋阴,润肠通便,截疟,祛风,解毒。
玉竹:本品为百合科植物玉竹的干燥根茎。味甘,性微寒;归肺、胃经;养阴润燥,生津止渴。
郁金:本品为姜科植物温郁金、姜黄、广西莪术或蓬莪术的干燥块根。味辛、苦,性寒;归肝、心、肺经;行气化瘀,清心解郁,利胆退黄。
蒺藜:本品为蒺藜科植物蒺藜的干燥成熟果实。味辛、苦,性微温; 归肝经;平肝解郁,活血祛风,明目,止痒。
茯苓:本品为多孔菌科真菌茯苓的干燥菌核。味甘、淡,性平;归心、脾、肾经;渗湿利水、健脾和胃、宁心安神。
丹参:本品为唇形科植物丹参的干燥根及根茎。味苦,性微寒;归心、肝经;祛瘀止痛,活血通经,清心除烦。
肉苁蓉:本品为列当科植物肉苁蓉的干燥带鳞叶的肉质茎。味甘、咸,性温;归肾、大肠经;补肾阳,益精血,润肠通便。
远志:本品为远志科植物远志或卵叶远志的干燥根。味苦、辛、性温;归心、肾、肺经;安神益智,祛痰,消肿。
桑葚子:本品为桑科植物桑的干燥果穗。味甘、酸,性寒;归心、肝、肾经;补血滋阴,生津润燥。
蜂蜜:蜂蜜是蜜蜂从开花植物的花中采得的花蜜在蜂巢中酿制的蜜。味甘,性平;入脾,胃,肺,大肠经;调补脾胃,缓急止痛,润肺止咳,润肠通便,润肤生肌,解毒。
陈皮:为芸香科植物橘及其栽培变种的成熟果皮。味苦、辛,性温;归肺、脾经;理气健脾,燥湿化痰。
甘草:本品为豆科植物甘草、胀果甘草或光果甘草的干燥根。味甘,性平;归心、肺、脾、胃经;补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。
本发明中药组方的方解:
本发明中药制剂的组方是以女贞子、黑芝麻、桑葚子、决明子、玉竹为君药,滋肝补肾、补血滋阴、清热润燥、生津止渴;以苍术、泽泻、蒺藜、茯苓为臣药,燥湿健脾、清湿利水、平肝解郁、健脾和胃;以何首乌、郁金、肉苁蓉、远志为佐药,养血滋阴、行气化瘀、润肠通便、祛痰消肿;以丹参、蜂蜜、陈皮为使药,活血通经、调补脾胃、理气健脾;以甘草调和诸药性,使诸药相辅相成、协同作用,共同达到滋肝补肾、补血滋阴、清热润燥、祛痰消肿、清湿利水、平肝解郁、活血通经、理气健脾等功效,对高血脂的治疗具有十分显著的治疗效果。
与现有技术相比,本发明中药制剂具有见效快、调治结合、治愈率高、治愈后不复发、无任何毒副作用等治疗优势,此外,其还具有制剂药效个体差异小、制剂药效稳定、制剂工艺简便易行、制剂工艺易于工业化批量生产。
本发明保健粥的配方分析:
中医论治高脂血症从调理肝、脾、肾三脏入手,并注重化痰祛瘀,肝、脾、肾三脏互相关联:肝主疏泄,气机调畅有助于脾的运化和升清。而脾的运化,升清又有助于肝的疏泄升发。肝脾调和,水谷精微的运化、输布正常,则痰湿无以生,病安从来。肾主藏精,为先天之本,脾之健运,化生精微,须借助于肾阳的温煦及肾阴的滋养;而肾中精气亦有赖于后天水谷精微的培育和充养,才能不断充盈和成熟。肝肾同源,肝血为肾精所化生,厥阴必待少阴之精足方能血充气畅,疏泄条达。治宜健脾化湿,气血双补,祛湿化痰。
本发明中药组方的方解:
本发明中药制剂的组方是以女贞子、黑芝麻、桑葚子、决明子、玉竹为君药,滋肝补肾、补血滋阴、清热润燥、生津止渴;以苍术、泽泻、蒺藜、茯苓为臣药,燥湿健脾、清湿利水、平肝解郁、健脾和胃;以何首乌、郁金、肉苁蓉、远志为佐药,养血滋阴、行气化瘀、润肠通便、祛痰消肿;以丹参、蜂蜜、陈皮为使药,活血通经、调补脾胃、理气健脾;以甘草调和诸药性,使诸药相辅相成、协同作用,共同达到滋肝补肾、补血滋阴、清热润燥、祛痰消肿、清湿利水、平肝解郁、活血通经、理气健脾等功效,对高血脂的治疗具有十分显著的治疗效果。
与现有技术相比,本发明中药制剂具有见效快、调治结合、治愈率高、治愈后不复发、无任何毒副作用等治疗优势,此外,其还具有制剂药效个体差异小、制剂药效稳定、制剂工艺简便易行、制剂工艺易于工业化批量生产。
与现有技术相比,本发明保健粥的技术优势在于,其秉承中国传统药膳的理念,将食品和药品的功效完美融合、相辅相成,既可以起到营养保健、辅助治疗的功效,又最大限度的避免了药物带来的毒副作用,适合患者长期食用;并且其保健效果好、应用范围广、制造工艺简便易行、易于推广应用。
具体实施方式
为了进一步验证本发明保健粥的功效,发明人选取几个有代表性的配方配比,进行了实践生产。
实施例1
以本发明原料配比范围内的任意值和制备方法的最佳工艺参数生产碗装粥。
(1)按配方配比分别准确称取燕麦5kg、玉米粉1.9kg、粳米2kg、黑芝麻0.3kg、中药提取物0.6kg;
中药提取物的配方:女贞子23份、苍术16份、泽泻15份、决明子18份、何首乌14份、玉竹18份、郁金12份、蒺藜15份、茯苓16份、丹参12份、肉苁蓉8份、远志11份、桑葚子26份、蜂蜜12份、陈皮13份、甘草11份;
(2)将苍术、何首乌、甘草炒制,分别粉碎,磨细,过80-120目筛,得细粉a,备用;
(3)将决明子、蒺藜、黑芝麻、茯苓、丹参、肉苁蓉分别粉碎,研磨,过80-120目筛,得细粉b,备用;
(4)将女贞子、玉竹、桑葚子、泽泻、郁金、远志、陈皮分别粉碎,混合后加入6-13倍重量的纯化水,回流煎煮三次,每次1-4小时,过滤,合并滤液,浓缩至60℃相对密度为1.23-1.26的浓缩液,备用;
(5)将步骤(4)中制得的浓缩液加入蜂蜜,混合均匀,继续浓缩至60℃相对密度为1.30-1.35 的稠膏,减压干燥,得干浸膏,粉碎磨细,过80-120目筛,得细粉c;
(6)将细粉a、b、c混合均匀,得中药提取物,备用;
(7)将燕麦、黑芝麻粉碎与玉米粉、粳米混合,加5-16倍的水,熬制30-120分钟,将中药提取物安配比加入,混合均匀,继续熬制2-15分钟,即为保健粥的原料粥;
(8)在步骤(7)的原料粥中加入蔗糖、食盐、香精、色素等辅料,制成甜味的保健营养粥,然后利用现代通用的食品包装技术可以制成碗粥,300ml/碗,中药成分含量折合生药为5.36g生药/碗。
实施例2
以本发明优选原料配比值和制备方法的最佳工艺参数生产碗装粥。
(1)按配方配比分别准确称取燕麦4.5kg、玉米粉3.5kg、粳米1.2kg、黑芝麻0.2kg、中药提取物0.6kg;
中药提取物的组成:女贞子25份、苍术18份、泽泻16份、决明子17份、何首乌15份、玉竹17份、郁金11份、蒺藜14份、茯苓15份、丹参13份、肉苁蓉9份、远志12份、桑葚子27份、蜂蜜13份、陈皮14份、甘草12份;
(2)将苍术、何首乌、甘草炒制,分别粉碎,磨细,过80-120目筛,得细粉a,备用;
(3)将决明子、蒺藜、黑芝麻、茯苓、丹参、肉苁蓉分别粉碎,研磨,过80-120目筛,得细粉b,备用;
(4)将女贞子、玉竹、桑葚子、泽泻、郁金、远志、陈皮分别粉碎,混合后加入6-13倍重量的纯化水,回流煎煮三次,每次1-4小时,过滤,合并滤液,浓缩至60℃相对密度为1.23-1.26的浓缩液,备用;
(5)将步骤(4)中制得的浓缩液加入蜂蜜,混合均匀,继续浓缩至60℃相对密度为1.30-1.35 的稠膏,减压干燥,得干浸膏,粉碎磨细,过80-120目筛,得细粉c;
(6)将细粉a、b、c混合均匀,得中药提取物,备用;
(7)将燕麦、黑芝麻粉碎与玉米粉、粳米混合,加5-16倍的水,熬制30-120分钟,将中药提取物安配比加入,混合均匀,继续熬制2-15分钟,即为保健粥的原料粥;
(8)在步骤(7)的原料粥中加入蔗糖、食盐、香精、色素等辅料,制成甜味的保健营养粥,然后利用现代通用的食品包装技术可以制成碗粥,300ml/碗,中药成分含量折合生药为5.36g生药/碗。
实施例3
以本发明原料优选配比的值和制备方法的最佳工艺参数生产不含中药提取物的碗装粥。
(1)按配方配比分别准确称取燕麦4.5kg、玉米粉3.5kg、粳米1.2kg、黑芝麻0.2kg;
(2)将燕麦、黑芝麻粉碎与玉米粉、粳米混合,加12倍的水,熬制60分钟,即为保健粥的原料粥;
(3)在步骤(2)的原料粥中加入蔗糖、食盐、香精、色素等辅料,制成甜味的保健营养粥,然后利用现代通用的食品包装技术可以制成碗粥,300ml/碗。
实施例4
以本发明原料优选配比的值和制备方法的最佳工艺参数生产只含中药提取物(以纯淀粉替代燕麦、玉米粉、粳米、黑芝麻)的碗装粥。
(1)按配方配比分别准确称取女贞子24份、苍术17份、泽泻14份、决明子19份、何首乌16份、玉竹18份、郁金13份、蒺藜16份、茯苓15份、丹参13份、肉苁蓉7份、远志13份、桑葚子28份、蜂蜜11份、陈皮14份、甘草12份。
(2)将苍术、何首乌、甘草炒制,分别粉碎,磨细,过80-120目筛,得细粉a,备用;
(3)将决明子、蒺藜、黑芝麻、茯苓、丹参、肉苁蓉分别粉碎,研磨,过80-120目筛,得细粉b,备用;
(4)将女贞子、玉竹、桑葚子、泽泻、郁金、远志、陈皮分别粉碎,混合后加入6-13倍重量的纯化水,回流煎煮三次,每次1-4小时,过滤,合并滤液,浓缩至60℃相对密度为1.23-1.26的浓缩液,备用;
(5)将步骤(4)中制得的浓缩液加入蜂蜜,混合均匀,继续浓缩至60℃相对密度为1.30-1.35 的稠膏,减压干燥,得干浸膏,粉碎磨细,过80-120目筛,得细粉c;
(6)将细粉a、b、c混合均匀,得中药提取物,备用;
(7)将纯淀粉,加12倍的水,熬制60分钟,将中药提取物安配比加入,混合均匀,继续熬制5分钟,即为保健粥的原料粥;
(8)在步骤(7)的原料粥中加入蔗糖、食盐、香精、色素等辅料,制成甜味的保健营养粥,然后利用现代通用的食品包装技术可以制成碗粥,300ml/碗,中药成分含量折合生药为5.36g生药/碗。
为了验证本发明保健粥的安全性,发明人用实施例1-4所生产的样品粥进行动物毒性试验。
本发明保健食品的毒性实验
1、急性毒性试验
用实施例1-4制备的保健粥进行急性毒性试验:取40只小鼠,口服灌胃最大值(最大给药体积的饱和量)162g/kg的该粥,连续观察7天,详细记录动物反应情况。结果表明:40只小鼠口服(灌胃)最大量后,活动均无异常,体重增加,无一死亡。且其食用量远超过人的食用量,为人食用量(按每日6碗)的6倍,表明其无急性毒性,食用安全性很高。
2、长期毒性试验:
采用Wistar大鼠以实施例1-4所生产的保健粥为主要食物,连续口服(灌胃)给药20周观察其长期毒性,并设空白对照组灌胃同等数量的饲料。试验动物外观行为活动基本正常;体重各组均呈上升趋势;病理学检查,各组动物脏器均未发现实质性细胞损害;血液学指标、血红蛋白(Hb)及白细胞计数值,血液生化指标谷丙转氨酸(SGDT,赖氏法)及尿素氮值(尿素酶法)等,各剂量组与空白对照组无明显差异(P>0.05)。说明本发明保健食品十分安全。
为了进一步验证本发明保健粥的临床保健效果,发明人还利用此粥进行了临床试验。
1、一般资料
本次临床试验的受试者来自某市第二人民医院,从该院门诊2014年3月至2016年5月收治的高血脂患者中,入组并完成该试验的患者452人,年龄24-68岁,平均年龄53.3岁。其中男272例,女180例。将所有患者按年龄、性别、病程、病情严重程度等平均分成对照1组、对照2组、对照3组和试验组,每组113例,男68例,女45例;使这4个组具备统计学意义上的可比性。
2、试验样品
对照品1:为试验特制的纯淀粉糊,规格300ml/碗;
对照品2:本发明实施例3所生产的不含中药提取物的碗装粥,规格300ml/碗;
对照品3:本发明实施例4所生产的只含中药成分(以纯淀粉替代燕麦、玉米粉、粳米、黑芝麻)碗装粥,规格300ml/罐,中药成分含量折合生药为5.36g生药/碗;
试验品:本发明实施例2所生产的碗装粥,规格300ml/罐,中药成分含量折合生药为5.36g生药/碗。
3、试验方法
所有受试者对医院既定的治疗手段和方法、用药等,均保持不变,在此基础上,对照1组食用对照品1,对照2组食用对照品2,对照3组食用对照品3,试验组食用试验品,每天两次,早晚各一次,每次一碗,随餐食用。连续食用3个月,试验期间检测血脂变化情况,记录患者的表征和试验结果。
4、保健和辅助治疗效果评价
(1)对比患者的表征,包括气色、精神状态、饮食、睡眠等。
(2)因本发明为保健品,只能起到增加医药治疗效果或辅助治疗的作用,所以对试验结果的评判以医学指标的评判结果为基础,来比较本发明保健食品是否有保健作用,因为医院对治疗效果不好或无效的患者会变更治疗手段,所以没有无效的患者。
5、试验结果统计分析
(1)表征结果比较:与三个对照组相比较,试验组的患者普遍气色较好、体感清爽、饮食旺健、且部分患者有明显的减肥现象。
(2)治疗结果统计分析:
所有患者试验结束后,将治疗结果统计分析如表1所示。
表1 治疗结果统计分析表
6、试验结论
表1试验结果显示,与对照1组相比,服用本发明保健食品的试验组,治疗的效果显著增强,治愈率提高了23.0个百分点,显效以上的治疗效果也提高了19.4个百分点。而对照2组和对照3组对治疗也有保健效果,治愈率分别提高了3.5和7.9个百分点,显效以上分别提高了5.3和9.7个百分点,但这两组提高之和均远小于试验组,因此,说明本发明保健食品配方中,谷物的营养成分和中药材发生了良好的协同作用,产生了一加一远大于二的效果,因此,本发明在保健食品领域取得了突破性的科技进展,其创造性是显而易见的。
Claims (4)
1.一种制备供高血脂患者食用的保健粥的方法,其特征在于:所述保健粥的配方以重量份可以表示为:燕麦20-60份、玉米粉15-50份、粳米2-30份、黑芝麻0.1-10份、中药提取物3-12份;
中药提取物的配方:女贞子17-29份、苍术10-22份、泽泻9-21份、决明子11-25份、何首乌8-20份、玉竹12-24份、郁金7-17份、蒺藜9-21份、茯苓10-22份、丹参8-16份、肉苁蓉6-10份、远志7-15份、桑葚子18-34份、蜂蜜7-17份、陈皮8-18份、甘草8-14份;
所述制备保健粥的方法为以下步骤:
(1)按本发明中药组方称取各味中药材;
(2)将苍术、何首乌、甘草炒制,分别粉碎,磨细,过80-120目筛,得细粉a,备用;
(3)将决明子、蒺藜、黑芝麻、茯苓、丹参、肉苁蓉分别粉碎,研磨,过80-120目筛,得细粉b,备用;
(4)将女贞子、玉竹、桑葚子、泽泻、郁金、远志、陈皮分别粉碎,混合后加入6-13倍重量的纯化水,回流煎煮三次,每次1-4小时,过滤,合并滤液,浓缩至60℃相对密度为1.23-1.26的浓缩液,备用;
(5)将步骤(4)中制得的浓缩液加入蜂蜜,混合均匀,继续浓缩至60℃相对密度为1.30-1.35 的稠膏,减压干燥,得干浸膏,粉碎磨细,过80-120目筛,得细粉c;
(6)将细粉a、b、c混合均匀,得中药提取物,备用;
(7)将燕麦、黑芝麻粉碎与玉米粉、粳米混合,加5-16倍的水,熬制30-120分钟,将中药提取物安配比加入,混合均匀,继续熬制2-15分钟,即为保健粥的原料粥;
(8)在步骤(7)的原料粥中加入蔗糖、食盐、香精、色素等辅料,利用现代通用的食品生产技术制成成品粥。
2.根据权利要求1所述的方法,其特征在于:所述保健粥的优选配方以重量份可以表示为:燕麦45份、玉米粉35份、粳米12份、黑芝麻2份、中药提取物6份;
中药提取物的组成:女贞子23份、苍术16份、泽泻15份、决明子18份、何首乌14份、玉竹18份、郁金12份、蒺藜15份、茯苓16份、丹参12份、肉苁蓉8份、远志11份、桑葚子26份、蜂蜜12份、陈皮13份、甘草11份。
3.根据权利要求1所述的方法,其特征在于:所述保健粥可以制成各种口味的保健营养粥,也可以通过真空干燥等技术制成可以冲泡的粉状粥。
4.根据权利要求1所述的方法,其特征在于:所述保健粥可以制成碗粥、易拉罐、袋装粥等多种包装形式。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811555206.5A CN111328967A (zh) | 2018-12-19 | 2018-12-19 | 一种制备供高血脂患者食用的保健粥的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811555206.5A CN111328967A (zh) | 2018-12-19 | 2018-12-19 | 一种制备供高血脂患者食用的保健粥的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111328967A true CN111328967A (zh) | 2020-06-26 |
Family
ID=71173675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811555206.5A Pending CN111328967A (zh) | 2018-12-19 | 2018-12-19 | 一种制备供高血脂患者食用的保健粥的方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111328967A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113951426A (zh) * | 2021-10-11 | 2022-01-21 | 刘世伟 | 一种治疗女性脱发的中药食疗粥及其制作方法 |
-
2018
- 2018-12-19 CN CN201811555206.5A patent/CN111328967A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113951426A (zh) * | 2021-10-11 | 2022-01-21 | 刘世伟 | 一种治疗女性脱发的中药食疗粥及其制作方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102986887B (zh) | 一种养生风味奶昔及其制备方法 | |
| CN103053748B (zh) | 一种葛根降脂降糖保健茶及其制备方法 | |
| CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
| CN104322617B (zh) | 一种辅助降血糖的饼干及其制备方法 | |
| CN105725055A (zh) | 一种酒药饼及其制作方法 | |
| CN103041209B (zh) | 一种治疗肾阴虚的中药制剂及其制备方法 | |
| CN106820062A (zh) | 具有调节体质功能的液体复合调味料及其制备方法 | |
| CN104491236A (zh) | 一种治疗原发性高血压的中药制剂及其制备方法 | |
| KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
| CN103054073B (zh) | 一种养颜鱼鳞冻及其制备方法 | |
| CN103230457B (zh) | 一种治疗病毒性心肌炎的中药组合物及其制备方法与用途 | |
| CN105994867A (zh) | 一种具有提高免疫力的巧克力及其制备方法 | |
| CN105056103A (zh) | 一种辅助降血脂降胆固醇的馒头及其制备方法 | |
| CN111328967A (zh) | 一种制备供高血脂患者食用的保健粥的方法 | |
| CN104984296A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
| CN104825821A (zh) | 一种治疗糖尿病的药物及其制备方法 | |
| KR101783549B1 (ko) | Dha 함유 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
| TW202330006A (zh) | 氣虛及/或血虛相關症狀之預防、改善或緩和用之組合物 | |
| CN106036906A (zh) | 一种养血安神富硒葛根龟苓膏及其制备方法 | |
| CN106376930A (zh) | 一种治疗慢性腹泻的营养药膳粉及其制备方法 | |
| CN106177651A (zh) | 一种小儿疳积药 | |
| CN105362629A (zh) | 一种含有杜仲的治疗女性更年期综合症的药物组合物及其制备方法 | |
| CN111328969A (zh) | 一种供高血脂患者食用的保健粥 | |
| CN106173128A (zh) | 一种具有抗疲劳功效的巧克力及其制备方法 | |
| CN105362630A (zh) | 一种治疗更年期综合症的药物组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200626 |
